Circulating RBP4 levels are among the changes that have been controversially discussed in the literature, with some studies finding higher levels in NAFLD (Terra et al, 2013) and some reporting unchanged levels (Zhou et al, 2017). This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatotic liver disease.